Hypobaric L5-S1 Study

RecruitingOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

July 22, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

June 30, 2025

Conditions
AnesthesiaAnesthesia, Local
Interventions
DRUG

Bupivacaine injection

A 3 mL hypobaric (0.33%) solution of bupivacaine, prepared by mixing 2 mL of isobaric (0.5%) bupivacaine with 1 mL of sterile water. Dural puncture will be performed using a 25 or 27G (gauge) spinal needle at the L5-S1 intervertebral space, and the 3 mL of 0.33% bupivacaine will be injected into the intrathecal space.

Trial Locations (1)

M5T 2S8

RECRUITING

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER